Women with mental illness less likely to receive cancer screenings
the ONA take:
According to a new study published in the journal Women's Health Issues, women with symptoms of serious mental illness are significantly less likely to receive Pap tests, mammograms, and clinical breast exams than women in the general population.
For the study, researcher Xiaoling Xiang, a doctoral candidate in social work, at the University of Illinois at Urbana-Champaign in Champaign, Illinois, analyzed data of more than 17,000 women from the U.S. Department of Health and Human Services' Medical Expenditure Panel Survey over a 3-year period. Xiang found over 1,300 women ages 40 to 74 who had symptoms of serious psychological distress.
Previous research has shown mentally ill patients lean toward using outpatient, inpatient, and emergency services more frequently than those in the general population, but patients with mental illness are estimated to die 14 to 32 years earlier than a person in the general population.
Despite the frequent use of the health care system, these patients are not receiving interventions and education to improve their use of preventive services. Xiang suggests that patients with mental illness require integrated primary and behavioral health care to treat patients with comorbid psychological and medical conditions.
Women with symptoms of serious mental illness are significantly less likely to receive routine cancer screening.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|